COVID-19 vaccine: Germany gives green light to first human trials

0
118

The New York Times says that Germany has joined the race for a vaccine, giving the green light to human trials of potential vaccines.

Germany gave the green light for human trials of potential coronavirus vaccines developed by German biotech company BioNTech, which is racing teams in Germany, the U.S. and China to develop an agent that will stop the pandemic.

The trial, only the fourth worldwide of a vaccine targeting the virus, will be initially conducted on 200 healthy people, with more subjects, including some at higher risk from the disease, to be included in a second stage, German vaccines regulator the Paul Ehrlich Institut said on Wednesday.